In this webinar, attendees will hear from leaders in the pharmacogenomics (PGx) space who will discuss the clinical importance of DPYD testing, consensus recommendations for DPYD variants and current testing methodologies. Although evidence clearly shows that certain DPYD variants are associated with an increased risk of severe toxicity from fluoropyrimidine therapy, pre-treatment DPYD testing can be challenging to implement at scale. This webinar explores how laboratories and health systems can translate recommendations into practice and support reliable, routine adoption of PGx testing.
The session will summarize current literature on DPYD implementation, with emphasis on operational barriers and factors that influence adoption, including provider education, EHR integration and reimbursement considerations. The discussion will highlight how tailored PGx reporting, discrete result data and workflow-aligned clinical integration can reduce friction at the point of care and support consistent ordering, interpretation and follow-through. Attendees will leave with practical considerations for reporting and workflow design that can lower implementation barriers and support broader PGx utilization.
Register for this webinar to learn how DPYD testing can be implemented from guidelines to go-live through practical PGx reporting and workflow design.
Speakers
Emily Morris, MSc CCGC, Account Executive, GenXys
Emily Morris is an Account Executive at GenXys and a board-certified Genetic Counselor. In her role at GenXys, she partners with laboratories and health systems to support successful pharmacogenomics and precision prescribing programs, with a focus on practical workflows, actionable reporting and integrated clinical decision support.
Message Presenter
Dr. Vicky Pratt, Director of Scientific Affairs, PGx, Agena Bioscience
Dr. Pratt is the Past President of the Association for Molecular Pathology. Dr. Pratt continues to serve on the Centers for Disease Control and Prevention (CDC) GeT-RM program for reference materials for Molecular Genetics, the National Academy of Medicine’s Roundtable on Genomics and Precision Health and the American Medical Association’s (AMA) Molecular Pathology Current Procedural Terminology (CPT) Advisory committee.
Dr. Pratt graduated with a PhD in Medical and Molecular Genetics from Indiana University School of Medicine. Her fellowship training was in PhD Medical and Clinical Molecular Genetics at Henry Ford Hospital, Detroit, MI.
Message Presenter
Who Should Attend?
This webinar is for audiences working in reference laboratories offering pharmacogenetic (PGx) testing, commercial companies offering PGx services or academic medical centers and hospitals offering PGx testing.
Relevant job titles include:
- Physician
- Pharmacist
- Laboratory Technician, Manager and Director
- Pathologist
- Medical Laboratory Scientist
- Medical Director and more
What You Will Learn
Attendees will gain insight into:
- Consensus recommendations for DPYDPGx testing
- Overcoming operational barriers and other factors influencing adoption
- Addressing common challenges often faced by laboratories and health systems
- Understanding how PGx reports and EHR integration can facilitate adoption
Xtalks Partners
Agena Bioscience
Agena Bioscience is dedicated to enabling targeted genomic discoveries that fit the realities of modern laboratories. For more than 25 years, we have partnered with molecular laboratories to help answer defined genetic questions quickly and efficiently – all with a single, flexible platform.
GenXys
GenXys is a configurable precision prescribing and intelligence platform that embeds actionable clinical insight into existing healthcare workflows. GenXys enables laboratories – from independent labs to large institutional environments – to operationalize complex clinical and genomic data at scale. Acting as the connective tissue across the prescribing journey, the platform orchestrates intelligence between laboratories, providers, payers, pharmacy benefit managers, and patients, ensuring the right information reaches the right stakeholder at the right time to support safer prescribing and efficient access to therapy.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account